NCT06320405 2025-12-29
Axatilimab in Combination With Retifanlimab and Paclitaxel for the Treatment of Patients With Advanced or Metastatic Solid Tumors
OHSU Knight Cancer Institute
Phase 1/2 Recruiting
OHSU Knight Cancer Institute
Fred Hutchinson Cancer Center
Centre Antoine Lacassagne
Centre Hospitalier Universitaire de Nice
University of Manchester
M.D. Anderson Cancer Center
Mayo Clinic
University of New Mexico
Elsan
Centre Hospitalier Universitaire de Nice
Institut Paoli-Calmettes
Gustave Roussy, Cancer Campus, Grand Paris
Gustave Roussy, Cancer Campus, Grand Paris
UMC Utrecht
University of Sao Paulo